J G Chemicals Earnings Call Transcript: Key Takeaways
Q2 FY27 record quarter: revenue ₹3,610 Mn (+63.9% YoY), EBITDA ₹387 Mn (10.72% margin), PAT ₹280 Mn (+86.7% YoY). H1 PAT ₹541 Mn. Capacity expansion underway.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
10 announcements with these filters
Q2 FY27 record quarter: revenue ₹3,610 Mn (+63.9% YoY), EBITDA ₹387 Mn (10.72% margin), PAT ₹280 Mn (+86.7% YoY). H1 PAT ₹541 Mn. Capacity expansion underway.
Q2 FY27 revenue ₹3,610Mn (+63.9% YoY), EBITDA ₹387Mn (10.72% margin), PAT ₹280Mn (+86.7% YoY). Dahej and Naidupeta capacity expansions drive growth.
J.G. Chemicals appointed Kaushik Roy and Sunil Duggal as Non-Executive Independent Directors for 36-month terms, effective 3 November 2026. Both bring extensive industrial and chemicals leadership experience.
J.G. Chemicals filed ICRA's monitoring agency report for the quarter ended 30-Sep-2026. It reports no deviation from the IPO objects.
J G Chemicals Ltd reported revenue from operations of ₹361 Cr (+63.9% YoY) and net profit of ₹28 Cr (+86.7% YoY) for Q2 FY27.
J.G. Chemicals will hold a board meeting on 3 Nov 2026 to approve Q2 and H1 FY27 unaudited results. No financial figures are disclosed in this advance intimation.
J.G. Chemicals filed its Reg 76 quarterly share capital reconciliation for Q1 FY27. No changes in share capital; 100% of shares held in demat form across NSDL and CDSL.
J.G. Chemicals Limited submitted the Regulation 74(5) certificate from its Registrar, KFin Technologies Limited, for the quarter ended September 30, 2026.
J.G. Chemicals Limited held its 25th Annual General Meeting on September 30, 2026. The meeting covered FY 2025-26 financial performance and standard AGM procedural matters.
CARE Edge Ratings assigned a CARE A+; Stable rating to J.G. Chemicals Limited's long-term bank facilities. Total facilities rated amount to ₹19.75 Crore.